Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - etoposide phosphate, quantity: 1136 mg (equivalent: etoposide, qty 1000 mg) - injection, powder for - excipient ingredients: sodium citrate dihydrate; dextran 40 - indications: for use in the treatment of: *small cell carcinoma of the lung *acute monocytic and myelomonocytic leukaemia *hodgkin's disease *non-hodgkin's lymphoma *testicular tumours.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - etoposide phosphate, quantity: 567.8 mg (equivalent: etoposide, qty 500 mg) - injection, powder for - excipient ingredients: sodium citrate dihydrate; dextran 40 - indications: for use in the treatment of: *small cell carcinoma of the lung *acute monocytic and myelomonocytic leukaemia *hodgkin's disease *non-hodgkin's lymphoma *testicular tumours.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - etoposide phosphate, quantity: 113.6 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; dextran 40 - for use in the treatment of: small cell carcinoma of the lung; acute monocytic and myelomonocytic leukaemia; hodgkin's disease; non- hodgkin's lymphoma and testicular tumours.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - indications as at 3 april 1996: etoposide injection is indicated for the following: small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia. hodgkin's disease. non-hodgkin's lymphoma

Irska - angleščina - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute; macrogol 300; citric acid - indications as at 3 april 1996: etoposide injection is indicated for the following: small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia. hodgkin's disease. non-hodgkin's lymphoma

Irska - angleščina - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

Irska - angleščina - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide

Irska - angleščina - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 50 milligram(s) - podophyllotoxin derivatives; etoposide

Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mylan healthcare sdn. bhd. - etoposide -